ストックスクリーナーアプリを入手
3.16
3.27%
0.10
Alto Neuroscience Inc (ANRO) 最新ニュース
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Alto Neuroscience | FinancialContent - FinancialContent
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 19, 2025 in Alto Neuroscience, Inc. LawsuitANRO - Morningstar
Bragar Eagel & Squire, P.C. Reminds Investors of Class - GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors of Class Actions Against Neogen, Alto, RxSight, and Replimune and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
Pomerantz Law Firm Announces the Filing of a Class Action Against Alto Neuroscience, Inc. and Certain OfficersANRO - PR Newswire
Contact The Gross Law Firm by September 19, 2025 Deadline to Join Class Action Against Alto Neuroscience, Inc.(ANRO) - PR Newswire
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
ANRO Investors Have Opportunity to Lead Alto Neuroscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Alto - GlobeNewswire
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Alto Neuroscience, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Using data models to predict Alto Neuroscience Inc. stock movementPortfolio Positioning Strategy With Timing - Newser
Real time pattern detection on Alto Neuroscience Inc. stockFree Trend Following Strategy With Stop Loss - Newser
Comparing Alto Neuroscience Inc. in custom built stock radarsLong-Term Growth Trend Summary With Confidence - Newser
Alto Neuroscience (ANRO) Projected to Post Quarterly Earnings on Tuesday - Defense World
Sector ETF performance correlation with Alto Neuroscience Inc.Short Term Profit Strategy with Entry Cues - Newser
Using AI based signals to follow Alto Neuroscience Inc.Free Low Risk Swing Trade Opportunity List - Newser
Financial Contrast: Swedish Orphan Biovitrum (OTCMKTS:BIOVF) and Alto Neuroscience (NYSE:ANRO) - Defense World
Real time alert setup for Alto Neuroscience Inc. performanceStock Entry Points Based on Technicals - Newser
Class Action Lawsuit Alert: Levi & Korsinsky Reminds Alto Neuroscience, Inc. (ANRO) Investors of September 19, 2025 Deadline - ACCESS Newswire
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Alto Neuroscience - MarketScreener
Alto Neuroscience and the Legal Quagmire: Assessing Risks and Investor Rights in a Post-IPO Meltdown - AInvest
Alto Neuroscience investors file class action lawsuit over securities fraud allegations. - AInvest
Alto Neuroscience, Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before September 19, 2025 to Discuss Your RightsANRO - PR Newswire
Analyzing drawdowns of Alto Neuroscience Inc. with statistical toolsShort-Term Profit Alert With Entry Forecast - Newser
Forecasting Alto Neuroscience Inc. price range with options dataFree Low Risk Picks for Daily Trading - Newser
ROSEN, A LONGSTANDING FIRM, Encourages Alto Neuroscience, - GlobeNewswire
Class Action Alert: Levi & Korsinsky Reminds Alto Neuroscience, Inc. (ANRO) Investors of September 19, 2025 Deadline - ACCESS Newswire
Shareholders that lost money on Alto Neuroscience, Inc.(ANRO) should contact The Gross Law Firm about pending Class ActionANRO - Morningstar
Levi & Korsinsky Urges Alto Neuroscience, Inc. (ANRO) Shareholders to Act Before Lead Plaintiff Deadline September 19, 2025 - ACCESS Newswire
Levi & Korsinsky Reminds Alto Neuroscience, Inc. Investors - GlobeNewswire
Why Alto Neuroscience Inc. is moving todayReliable Setup Screener with Low Risk - Newser
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Alto Neuroscience - Morningstar
Alto Neuroscience Inc. Crosses 200 Day MA — Signal or NoiseCapital Protection Trading Strategies Gain Interest - beatles.ru
Shareholders that lost money on Alto Neuroscience, Inc.(ANRO) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - PR Newswire
Allianz Asset Management GmbH Trims Stock Holdings in Alto Neuroscience, Inc. (NYSE:ANRO) - Defense World
Why Alto Neuroscience Inc. stock attracts strong analyst attentionMonthly Trade Result and Signal Summary - Newser
Quant Tools Rank Alto Neuroscience Inc. as High Risk High RewardInvestment Playbook for Growing Markets Shared - beatles.ru
ANRO Investors Have Opportunity to Lead Alto Neuroscience, Inc. Securities Fraud Lawsuit - PR Newswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Alto Neuroscience, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Alto Neuroscience, Inc. Investigated for Breaches of Fiduciary DutyContact the DJS Law Group to Discuss Your Rights – ANRO - The Globe and Mail
ANRO SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Alto Neuroscience, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Investors Urged to Contact Levi & Korsinsky for Information Before September 19, 2025Alto Neuroscience, Inc. (ANRO) - TradingView
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 19, 2025 in Alto Neuroscience, Inc. LawsuitANRO - PR Newswire
ALTO NEUROSCIENCE, INC. (NYSE: ANRO) SHAREHOLDER ALERT - GlobeNewswire
Tools to assess Alto Neuroscience Inc.’s risk profileFree Capital Protection Trading Strategies - Newser
Published on: 2025-08-04 06:43:16 - Jammu Links News
Why is Alto Neuroscience Inc. stock attracting strong analyst attentionAchieve rapid portfolio appreciation today - Jammu Links News
ANRO INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Alto Neuroscience, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
What analysts say about Alto Neuroscience Inc. stockStay informed with daily expert analysis - Jammu Links News
Alto Neuroscience Inc. Stock Analysis and ForecastBuild wealth with professional market analysis - Jammu Links News
ANRO Investors Have the Opportunity to Lead the Alto Neuroscience Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - PR Newswire
What is the risk reward ratio of investing in Alto Neuroscience Inc. stockUnlock daily market insights for better trades - Jammu Links News
What institutional investors are buying Alto Neuroscience Inc. stockUnstoppable investment returns - Jammu Links News
What are analysts’ price targets for Alto Neuroscience Inc. in the next 12 monthsInvest smarter with real-time trading signals - Jammu Links News
Bragar Eagel & Squire, P.C. Is Reminds Investors of Class - GlobeNewswire
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Alto Neuroscience - GlobeNewswire
0.94%
2.87%
大文字化:
|
ボリューム (24 時間):